Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Medical News

St. Louis University to Begin Trial of Preventive Hepatitis C Vaccine

November 18, 2003

St. Louis University's Center for Vaccine Development is launching the first clinical trial of a hepatitis C vaccine in the United States, the St. Louis Post-Dispatch reports. The trial, which will be conducted in conjunction with Emeryville, Calif.-based biotechnology company Chiron, is the first human trial to test a preventive hepatitis C vaccine; Belgian researchers are currently conducting a trial of a therapeutic hepatitis C vaccine. Researchers hope to administer the vaccine to 45 healthy participants and then test their blood for an immune system reaction to the vaccine, the Post-Dispatch reports. The vaccine contains no live virus and therefore cannot infect participants with hepatitis C. The vaccine is made from parts of the virus' shell, the outside parts of the virus that are recognized by the immune system. Currently, there are six main types of hepatitis C with dozens of variants of each type. The vaccine is aimed at the most common type of the virus, but researchers do not know how the vaccine will perform against other variants, the Post-Dispatch reports. Dr. Robert Belshe, director of the SLU vaccine center, said, "This is not likely to be the final vaccine for all hepatitis C viruses, though it is an important step" (Kintisch, St. Louis Post-Dispatch, 11/17).

Back to other news for November 18, 2003


Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2003 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
More HIV News
Advertisement:
Find out how a Walgreens specially trained pharmacist can help you

Tools
 

Advertisement